These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor. Fernández de Larrea C; Isola I; Pereira A; Cibeira MT; Bladé J; Rosiñol L Leukemia; 2018 Sep; 32(9):2082-2094. PubMed ID: 29795240 [No Abstract] [Full Text] [Related]
26. Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia. Correa JG; Cibeira MT; Tovar N; Isola I; Pedrosa F; Díaz T; Lozano E; Magnano L; Rosiñol L; Bladé J; Fernández de Larrea C Br J Haematol; 2017 Dec; 179(5):849-851. PubMed ID: 27605200 [No Abstract] [Full Text] [Related]
27. [CME: Multiple Myeloma - a Review]. Bräutigam M; Biskup E Praxis (Bern 1994); 2018 Jul; 107(14):749-754. PubMed ID: 29969971 [TBL] [Abstract][Full Text] [Related]
28. Timing of treatment of smoldering myeloma: delay until progression. Kumar SK Blood Adv; 2018 Nov; 2(21):3050-3053. PubMed ID: 30425069 [TBL] [Abstract][Full Text] [Related]